Personal Injury Law


Office Locations

(Map and Directions)
3375-A Capital Circle N.E.
Tallahassee, FL 32308
Toll Free Phone: (877) ALL WE DO
Local Phone: (850) 553-HELP
or (850) 422-7773
Fax: (850) 422-3449

(Map and Directions)
214 West Jackson Street
Thomasville, GA 31792
Toll Free Phone: (877) ALL WE DO
Local Phone: (229) 226-HELP
(229) 226-4357


Video Messages


The Wall Street Journal reported that two drug-safety experts have authored an article revealing an FDA effort to speed approval of new medicines may have allowed a drug for stroke prevention onto the market without proper safety analysis. 

In an article published in the Journal of the American Medical Association, Thomas J. Moore and Curt D. Furberg wrote that the Food and Drug Administration's push to get medicines to market may have compromised prescription-drug safety.

"These examples raise the question of whether it was good policy to approve three innovative new drugs with significant safety questions unanswered," Mr. Moore and Dr. Furberg wrote.

One of the drug cited is Pradaxa.  Since its launch in 2010, the Boehringer blood thinner has been linked to thousands of adverse event reports and hundreds of cases of fatal bleeding. The FDA is currently reviewing case reports.  After its own review, European regulators asked for label changes, but said the drug's benefits are still worth the risk for appropriate patients.

The article authors noted in some ways Pradaxa is easier to use than the decades-old competing anticoagulant, warfarin. However, the authors also described Pradaxa's bleeding risk and said bleeding with Pradaxa patients "may be more difficult to treat than warfarin-related bleeding."

Apparently troubling to the authors was their finding that "no antidote is available for use in bleeding emergencies" linked to Pradaxa.  Manufacturer Boehringer Ingelheim didn't immediately respond to questions, but it has noted in its literature that the drug is "used to reduce the risk of stroke and blood clots" in patients with an aberrant heartbeat called atrial fibrillation.

If you or a loved one has taken Pradaxa and suffered uncontrolled bleeding, renal failure, stroke and/or death you may be entitled to financial compensation.

For a free evaluation and consultation, contact us at: (800) 876-7773


  • Fonvielle Lewis Messer & McConnaughhay  •  3375 Capital Circle NE, Tallahassee, Florida 32308   •  (850) 422-7773  •  Contact Us